Drug name
Last update: Sep 20263BNC117
Developer(s)
Drug information
Not provided
3BNC117
investigational
Biotherapeutic
Not provided
Not provided
Unknown
Unknown
Therapeutic area(s)
- HIV
- Treatment
Administration route
Intravenous
Associated long-acting platforms
Monoclonal antibodies and antibody drug conjugates
Use of drug
- Administered by a nurse
- Administered by a specialty health worker
- Other/Variable/Unknown : To be determined
Dosage
Not provided
Not provided
Not provided
Not provided
Not provided
Associated compounds, formulations and regimens
Associated technologies
Not provided
Additional information
Developer(s)
Gilead
Frontier Biotechnologies
Rockefeller University
Drug structure
Scale-up and manufacturing prospects
Not provided
Not provided
Not provided
Not provided
Excipients & delivery device(s)
Not provided
Not provided
Not provided
Not provided
Safety, Efficacy and Evidence Summary
Not provided
Not provided
Not provided
Not provided
There are either no relevant patents or these were not yet submitted to LAPaL